Axial myopathy: An overlooked feature of muscle diseases

Brain

Volumn 139, Issue 1, 2016, Pages 13-22

  Witting, Nanna ^a   Andersen, Linda K ^a   Vissing, John ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Axial; Myopathy; Paraspinal; Rigid spine

Indexed keywords

ARTICLE; AXIAL MYOPATHY; CLINICAL EVALUATION; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DYNAMOMETER; DYNAMOMETRY; ELECTROMYOGRAPHY; FIXED DYNAMOMETRY; HAND HELD DYNAMOMETRY; HUMAN; MOTOR PERFORMANCE; MUSCLE BIOPSY; MUSCLE STRENGTH; MYOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MOBILITY; PRIORITY JOURNAL; CLASSIFICATION; MUSCLE DISEASE; PARASPINAL MUSCLE; PATHOLOGY; SKELETAL MUSCLE;

HUMANS; MUSCLE, SKELETAL; MUSCULAR DISEASES; PARASPINAL MUSCLES;

EID: 84964680361     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awv332     Document Type: Article

References (80)

1. Bandholm T, Rose MH, Sonne-Holm S, Jensen BR. Assessment of torque-steadiness reliability at the ankle level in healthy young subjects: implications for cerebral palsy. Eur J Appl Physiol 2008;104:609-15.
2. Behin A, Jardel C, Claeys KG, Fagart J, Louha M, Romero NB, et al. Adult cases of mitochondrial DNA depletion due to TK2 defect: an expanding spectrum. Neurology 2012;78:644-8.
3. Bogduk N. Degenerative joint disease of the spine. Radiol Clin North Am 2012;50:613-28.
4. Bonne G, Mercuri E, Muchir A, Urtizberea A, Becane HM, Recan D, et al. Clinical and molecular genetic spectrum of autosomal dominant Emery-Dreifuss muscular dystrophy due to mutations of the lamin A/C gene. Ann Neurol 2000;48:170-80.
5. Brinkmann JR. Comparison of a hand-held and fixed dynamometer in measuring strength of patients with neuromuscular disease. J Orthop Sports Phys Ther 1994;19:100-4.
6. Chauveau C, Bonnemann CG, Julien C, Kho AL, Marks H, Talim B, et al. Recessive TTN truncating mutations define novel forms of core myopathy with heart disease. Hum Mol Genet 2014;23:980-91.
7. Chemla JC, Kanter RJ, Carboni MP, Smith EC. Two children with "dropped head" syndrome due to lamin A/C mutations. Muscle Nerve 2010;42:839-41.
8. Claeys KG, Fardeau M. Myofibrillar myopathies. Handb Clin Neurol 2013;113:1337-42.
9. Clarkson HM. Musculoskeletal assessment. Joint range of motion and manual muscle strength. Baltimore: Lippincott Williams & Wilkins; 2000.
10. Colombo R, Mazzini L, Mora G, Parenzan R, Creola G, Pirali I, et al. Measurement of isometric muscle strength: a reproducibility study of maximal voluntary contraction in normal subjects and amyotrophic lateral sclerosis patients. Med Eng Phys 2000;22:167-74.
11. Cowling BS, Cottle DL, Wilding BR, D'Arcy CE, Mitchell CA, McGrath MJ. Four and a half LIM protein 1 gene mutations cause four distinct human myopathies: a comprehensive review of the clinical, histological and pathological features. Neuromuscul Disord 2011;21:237-51.
12. Dahlqvist JR, Vissing CR, Thomsen C, Vissing J. Severe paraspinal muscle involvement in facioscapulohumeral muscular dystrophy. Neurology 2014;83:1178-83.
13. Dixon WT. Simple proton spectroscopic imaging. Radiology 1984;153:189-94.
14. Dupeyron A, Stober N, Gelis A, Castelnovo G, Labauge P, Pelissier J. Painful camptocormia: the relevance of shaking your patient's hand. Eur Spine J 2010;19 Suppl 2:S87-90.
15. Forrest KM, Al-Sarraj S, Sewry C, Buk S, Tan SV, Pitt M, et al. Infantile onset myofibrillar myopathy due to recessive CRYAB mutations. Neuromuscul Disord 2011;21:37-40.
16. Gaeta M, Mazziotti S, Toscano A, Rodolico C, Mazzeo A, Blandino A. "Dropped-head" syndrome due to isolated myositis of neck extensor muscles: MRI findings. Skeletal Radiol 2006;35:110-12.
17. Ghosh PS, Milone M. Camptocormia as presenting manifestation of a spectrum of myopathic disorders. Muscle Nerve 2015a. Advance Access published on April 21, 2015, doi: 10.1002/mus.24689.
18. Ghosh PS, Milone M. Clinical and laboratory findings of 21 patients with radiation-induced myopathy. J Neurol Neurosurg Psychiatry 2015b;86:152-8.
19. Goodman BP, Liewluck T, Crum BA, Spinner RJ. Camptocormia due to inclusion body myositis. J Clin Neuromuscul Dis 2012;14:78-81.
20. Gruther W, Wick F, Paul B, Leitner C, Posch M, Matzner M, et al. Diagnostic accuracy and reliability of muscle strength and endurance measurements in patients with chronic low back pain. J Rehabil Med 2009;41:613-19.
21. Hiniker A, Wong LJ, Berven S, Truong CK, Adesina AM, Margeta M. Axial mitochondrial myopathy in a patient with rapidly progressive adult-onset scoliosis. Acta Neuropathol Commun 2014;2:137.
22. Hoagland RJ, Mendoza M, Armon C, Barohn RJ, Bryan WW, Goodpasture JC, et al. Reliability of maximal voluntary isometric contraction testing in a multicenter study of patients with amyotrophic lateral sclerosis. Syntex/Synergen Neuroscience Joint Venture rhCNTF ALS Study Group. Muscle Nerve 1997;20:691-5.
23. Hobson-Webb LD, Dearmey S, Kishnani PS. The clinical and electrodiagnostic characteristics of Pompe disease with post-enzyme replacement therapy findings. Clin Neurophysiol 2011;122:2312-17.
24. Hund E, Heckl R, Goebel HH, Meinck HM. Inclusion body myositis presenting with isolated erector spinae paresis. Neurology 1995;45:993-94.
25. Jarraya M, Quijano-Roy S, Monnier N, Behin A, vila-Smirnov D, Romero NB, et al. Whole-Body muscle MRI in a series of patients with congenital myopathy related to TPM2 gene mutations. Neuromuscul Disord 2012;22(Suppl 2):S137-47.
26. Jungbluth H, Sewry CA, Muntoni F. Core myopathies. Semin Pediatr Neurol 2011;18:239-49.
27. Kaneko K, Kuroda H, Izumi R, Tateyama M, Kato M, Sugimura K, et al. A novel mutation in PNPLA2 causes neutral lipid storage disease with myopathy and triglyceride deposit cardiomyovasculopathy: a case report and literature review. Neuromuscul Disord 2014;24:634-41.
28. Kastrup A, Gdynia HJ, Nagele T, Riecker A. Dropped-head syndrome due to steroid responsive focal myositis: a case report and review of the literature. J Neurol Sci 2008;267:162-5.
29. Katz JS, Wolfe GI, Burns DK, Bryan WW, Fleckenstein JL, Barohn RJ. Isolated neck extensor myopathy: a common cause of dropped head syndrome. Neurology 1996;46:917-21.
30. Kendall FP. Muscles: testing and function with posture and pain. Baltimore: Lippincott Williams & Wilkins; 2005.
31. Kesper K, Kornblum C, Reimann J, Lutterbey G, Schroder R, Wattjes MP. Pattern of skeletal muscle involvement in primary dysferlinopathies: a whole-body 3. 0-T magnetic resonance imaging study. Acta Neurol Scand 2009;120:111-18.
32. Kley RA, Hellenbroich Y, van der Ven PF, Furst DO, Huebner A, Bruchertseifer V, et al. Clinical and morphological phenotype of the filamin myopathy: a study of 31 German patients. Brain 2007;130:3250-64.
33. Kocaaga Z, Bal S, Turan Y, Gurgan A, Esmeli F. Camptocormia and dropped head syndrome as a clinic picture of myotonic myopathy. Joint Bone Spine 2008;75:730-33.
34. Kornblum C, Lutterbey G, Bogdanow M, Kesper K, Schild H, Schroder R, et al. Distinct neuromuscular phenotypes in myotonic dystrophy types 1 and 2: a whole body highfield MRI study. J Neurol 2006;253:753-61.
35. Laforet P, Doppler V, Caillaud C, Laloui K, Claeys KG, Richard P, et al. Rigid spine syndrome revealing late-onset Pompe disease. Neuromuscul Disord 2010;20:128-30.
36. Liewluck T, Goodman BP. Late-onset axial myopathy and camptocormia in a calpainopathy carrier. J Clin Neuromuscul Dis 2012;13:209-13.
37. Loseth S, Voermans NC, Torbergsen T, Lillis S, Jonsrud C, Lindal S, et al. A novel late-onset axial myopathy associated with mutations in the skeletal muscle ryanodine receptor (RYR1) gene. J Neurol 2013;260:1504-10.
38. Ma H, McEvoy KM, Milone M. Sporadic inclusion body myositis presenting with severe camptocormia. J Clin Neurosci 2013;20:1628-9.
39. Maggi L, D'Amico A, Pini A, Sivo S, Pane M, Ricci G, et al. LMNA-associated myopathies: The Italian experience in a large cohort of patients. Neurology 2014;83:1634-44.
40. Mannion AF, Dumas GA, Cooper RG, Espinosa FJ, Faris MW, Stevenson JM. Muscle fibre size and type distribution in thoracic and lumbar regions of erector spinae in healthy subjects without low back pain: normal values and sex differences. J Anat 1997a;190(Pt 4):505-13.
41. Mannion AF, Kaser L, Weber E, Rhyner A, Dvorak J, Muntener M. Influence of age and duration of symptoms on fibre type distribution and size of the back muscles in chronic low back pain patients. Eur Spine J 2000;9:273-81.
42. Mannion AF, Weber BR, Dvorak J, Grob D, Muntener M. Fibre type characteristics of the lumbar paraspinal muscles in normal healthy subjects and in patients with low back pain. J Orthop Res 1997b;15:881-7.
43. Mattar MA, Gordo JM, Halpern AS, Shinjo SK. Camptocormia secondary to polymyositis. Rev Bras Reumatol 2013;53:368-70.
44. Mercuri E, Clements E, Offiah A, Pichiecchio A, Vasco G, Bianco F, et al. Muscle magnetic resonance imaging involvement in muscular dystrophies with rigidity of the spine. Ann Neurol 2010;67:201-8.
45. Mercuri E, Poppe M, Quinlivan R, Messina S, Kinali M, Demay L, et al. Extreme variability of phenotype in patients with an identical missense mutation in the lamin A/C gene: from congenital onset with severe phenotype to milder classic Emery-Dreifuss variant. Arch Neurol 2004;61:690-4.
46. Moreland J, Finch E, Stratford P, Balsor B, Gill C. Interrater reliability of six tests of trunk muscle function and endurance. J Orthop Sports Phys Ther 1997;26:200-8.
47. Muller TJ, Kraya T, Stoltenburg-Didinger G, Hanisch F, Kornhuber M, Stoevesandt D, et al. Phenotype of matrin-3-related distal myopathy in 16 German patients. Ann Neurol 2014;76:669-80.
48. Muppidi S, Saperstein DS, Shaibani A, Nations SP, Vernino S, Wolfe GI. Isolated neck extensor myopathy: is it responsive to immunotherapy? J Clin Neuromuscul Dis 2010;12:26-9.
49. Narayanaswami P, Bertorini TE, Halford H, III. Selective paraspinal muscle amyotrophy. J Neurol Sci 2000;176:70-4.
50. Newton M, Thow M, Somerville D, Henderson I, Waddell G. Trunk strength testing with iso-machines. Part 2: Experimental evaluation of the Cybex II Back Testing System in normal subjects and patients with chronic low back pain. Spine 1993;18:812-24.
51. Nguyen K, Bassez G, Krahn M, Bernard R, Laforet P, Labelle V, et al. Phenotypic study in 40 patients with dysferlin gene mutations: high frequency of atypical phenotypes. Arch Neurol 2007;64:1176-82.
52. Park JM, Kim YJ, Yoo JH, Hong YB, Park JH, Koo H, et al. A novel MYH7 mutation with prominent paraspinal and proximal muscle involvement. Neuromuscul Disord 2013;23:580-6.
53. Peolsson A, Oberg B, Hedlund R. Intra- and inter-tester reliability and reference values for isometric neck strength. Physiother Res Int 2001;6:15-26.
54. Personius KE, Pandya S, King WM, Tawil R, McDermott MP. Facioscapulohumeral dystrophy natural history study: standardization of testing procedures and reliability of measurements. The FSH DY Group. Phys Ther 1994;74:253-63.
55. Prigogine C, Richard P, Van den BP, Groswasser J, Deconinck N. Novel LMNA mutation presenting as severe congenital muscular dystrophy. Pediatr Neurol 2010;43:283-6.
56. Quane KA, Healy JM, Keating KE, Manning BM, Couch FJ, Palmucci LM, et al. Mutations in the ryanodine receptor gene in central core disease and malignant hyperthermia. Nat Genet 1993;5:51-5.
57. Quijano-Roy S, Avila-Smirnow D, Carlier RY. Whole body muscle MRI protocol: pattern recognition in early onset NM disorders. Neuromuscul Disord 2012;22(Suppl 2):S68-84.
58. Quijano-Roy S, Mbieleu B, Bonnemann CG, Jeannet PY, Colomer J, Clarke NF, et al. De novo LMNA mutations cause a new form of congenital muscular dystrophy. Ann Neurol 2008;64:177-86.
59. Quinlivan R, Buckley J, James M, Twist A, Ball S, Duno M, et al. McArdle disease: a clinical review. J Neurol Neurosurg Psychiatry 2010;81:1182-8.
60. Quinzii CM, Vu TH, Min KC, Tanji K, Barral S, Grewal RP, et al. X-linked dominant scapuloperoneal myopathy is due to a mutation in the gene encoding four-and-a-half-LIM protein 1. Am J Hum Genet 2008;82:208-13.
61. Roussel NA, Truijen S, De Kerf, I, Lambeets D, Nijs J, Stassijns G. Reliability of the assessment of lumbar range of motion and maximal isometric strength in patients with chronic low back pain. Arch Phys Med Rehabil 2008;89:788-91.
62. Roy MA, Doherty TJ. Reliability of hand-held dynamometry in assessment of knee extensor strength after hip fracture. Am J Phys Med Rehabil 2004;83:813-18.
63. Sakiyama Y, Okamoto Y, Higuchi I, Inamori Y, Sangatsuda Y, Michizono K, et al. A new phenotype of mitochondrial disease characterized by familial late-onset predominant axial myopathy and encephalopathy. Acta Neuropathol 2011;121:775-83.
64. Salem B, Thaisetthawatkul P, Fernandes JA, McComb RD. Adultonset acid maltase deficiency with isolated axial muscle involvement. J Clin Neuromuscul Dis 2010;12:30-5.
65. Schramm N, Born C, Weckbach S, Reilich P, Walter MC, Reiser MF. Involvement patterns in myotilinopathy and desminopathy detected by a novel neuromuscular whole-body MRI protocol. Eur Radiol 2008;18:2922-36.
66. Schreckenbach T, Henn W, Kress W, Roos A, Maschke M, Feiden W, et al. Novel FHL1 mutation in a family with reducing body myopathy. Muscle Nerve 2013;47:127-34.
67. Schreckenbach T, Schroder JM, Voit T, Abicht A, Neuen-Jacob E, Roos A, et al. Novel TPM3 mutation in a family with cap myopathy and review of the literature. Neuromuscul Disord 2014;24:117-24.
68. Selcen D, Muntoni F, Burton BK, Pegoraro E, Sewry C, Bite AV, et al. Mutation in BAG3 causes severe dominant childhood muscular dystrophy. Ann Neurol 2009;65:83-9.
69. Shi Z, Hayashi YK, Mitsuhashi S, Goto K, Kaneda D, Choi YC, et al. Characterization of the Asian myopathy patients with VCP mutations. Eur J Neurol 2012;19:501-9.
70. Stark T, Walker B, Phillips JK, Fejer R, Beck R. Hand-held dynamometry correlation with the gold standard isokinetic dynamometry: a systematic review. PM R 2011;3:472-9.
71. Susman RD, Quijano-Roy S, Yang N, Webster R, Clarke NF, Dowling J, et al. Expanding the clinical, pathological and MRI phenotype of DNM2-related centronuclear myopathy. Neuromuscul Disord 2010;20:229-37.
72. Tasca G, Monforte M, Iannaccone E, Laschena F, Ottaviani P, Silvestri G, et al. Muscle MRI in female carriers of dystrophinopathy. Eur J Neurol 2012;19:1256-60.
73. Thorborg K, Petersen J, Magnusson SP, Holmich P. Clinical assessment of hip strength using a hand-held dynamometer is reliable. Scand J Med Sci Sports 2010;20:493-501.
74. Visser J, Mans E, de Visser M, van den Berg-Vos RM, Franssen H, de Jong JM, et al. Comparison of maximal voluntary isometric contraction and hand-held dynamometry in measuring muscle strength of patients with progressive lower motor neuron syndrome. Neuromuscul Disord 2003;13:744-50.
75. Wang CY, Olson SL, Protas EJ. Test-retest strength reliability: handheld dynamometry in community-dwelling elderly fallers. Arch Phys Med Rehabil 2002;83:811-15.
76. Watts GD, Wymer J, Kovach MJ, Mehta SG, Mumm S, Darvish D, et al. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat Genet 2004;36:377-81.
77. Windpassinger C, Schoser B, Straub V, Hochmeister S, Noor A, Lohberger B, et al. An X-linked myopathy with postural muscle atrophy and generalized hypertrophy, termed XMPMA, is caused by mutations in FHL1. Am J Hum Genet 2008;82:88-99.
78. Witting N, Duno M, Piraud M, Vissing J. Severe axial myopathy in McArdle disease. JAMA Neurol 2014;71:88-90.
79. Wrede A, Margraf NG, Goebel HH, Deuschl G, Schulz-Schaeffer WJ. Myofibrillar disorganization characterizes myopathy of camptocormia in Parkinson's disease. Acta Neuropathol 2012;123:419-32.
80. Zoabli G, Mathieu PA, Aubin CE. Magnetic resonance imaging of the erector spinae muscles in Duchenne muscular dystrophy: implication for scoliotic deformities. Scoliosis 2008;3:21.